Cardiac Rehabilitation and Heart Failure With Preserved Ejection Fraction. [PDF]
Hirashiki A, Shimizu A.
europepmc +1 more source
Phenotyping of acute heart failure with preserved ejection fraction: real-world outcomes in a cohort of older patients. [PDF]
Burzo ML +10 more
europepmc +1 more source
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad +9 more
wiley +1 more source
Ventricular-Arterial Coupling in Heart Failure with Preserved Ejection Fraction: A Bibliometric Review and Clinical Implications. [PDF]
Li T, Luo Y, Zhao L, Lu F, Zhang B.
europepmc +1 more source
A Near-Miss Event: Constrictive Pericarditis Misdiagnosed as Heart Failure With Preserved Ejection Fraction. [PDF]
Rayamajhi K +4 more
europepmc +1 more source
Cardiac Magnetic Resonance Imaging in Heart Failure With Preserved Ejection Fraction. [PDF]
Kikuchi DS +5 more
europepmc +1 more source
Cardiac remodeling and arrhythmia in a mouse model of Depdc5 haploinsufficiency
Abstract Objective Some ion channel genes linked to developmental and epileptic encephalopathy (DEE) are also linked to cardiac arrhythmia, leading to the hypothesis that predisposition to cardiac arrhythmias may contribute to the complex disease presentation of DEE and possibly to the mechanism of sudden unexpected death in epilepsy.
Roberto Ramos‐Mondragon +9 more
wiley +1 more source
Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction. [PDF]
Krüger N +7 more
europepmc +1 more source

